IMSCC Resource Library
Sort
Categories
- Biologics/IVD 17
- Clinical Trial Guidance 29
- Laboratory 7
- Medical Device 17
- Medical Device and Biologics/IVD 2
- Medical Device and Software 1
- Quality System 19
- Regulatory Submissions 63
- Software 8
- Software and Regulatory 1
- Software and Regulatory Submissions 2
Tags
- 510k 17
- Adverse Events 3
- Antimicrobial 3
- Audit 2
- Biologics/IVD 25
- Breakthrough Devices Program 1
- Clinical Trial 32
- Combination Product 1
- Cybersecurity 5
- De Novo Submission 6
- Device 16
- Devices 2
- Drug 7
- FDA Fees 5
- Human Factors 1
- Investigational Device Exemption (IDE) 3
- Labeling 16
- Laboratory 6
- Machine Learning/Artificaial Intelligance 1
- Manufacturing 7
- Pediatrics 4
- Performance Testing 3
- Post-Market 2
- Post-Market Studies 4
- Pre-Clinical Studies: Regulatory Submission 1
- Premarket Approval Application 14
- Quality System 20
- Recalls 1
- Regulatory Inspection 2
- Regulatory Submission 70
- Risk Management 21
- Software 13
- User Fees 1
- Validation 4
Regulatory Submissions
Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program: Guidance for Industry and Food and Drug Administration Staff
January 6, 2021
Regulatory Submissions
Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics: Guidance for Industry and Food and Drug Administration Staff
September 25, 2018
Clinical Trial Guidance
Acceptance of Clinical Data to Support Medical Device Applications and Submissions: Frequently Asked Questions: Guidance for Industry and Food and Drug Administration Staff
February 21, 2018
Software
Software as a Medical Device (SAMD): Clinical Evaluation: Guidance for Industry and Food and Drug Administration Staff
December 8, 2017
Regulatory Submissions
Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices : Guidance for Industry and Food and Drug Administration Staff
August 31, 2017
Clinical Trial Guidance
Factors to Consider When Making Benefit-Risk Determinations for Medical Device Investigational Device Exemptions: Guidance for Investigational Device Exemption Sponsors, Sponsor-Investigators and Food and Drug Administration Staff
January 13, 2017
Regulatory Submissions
The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]: Guidance for Industry and Food and Drug Administration Staff
July 28, 2014
Biologics/IVD
In Vitro Diagnostic (IVD) Device Studies – Frequently Asked Questions: Guidance for Industry and FDA Staff
June 25, 2010
Regulatory Submissions
Guidance on Section 216 of the Food and Drug Administration Modernization Act of 1997 – Guidance for Industry and for FDA Reviewers
August 9, 2000
Regulatory Submissions
Early Collaboration Meetings Under the FDA Modernization Act (FDAMA); Final Guidance for Industry and for CDRH Staff
February 28, 2001
Medical Device
Guidance on Medical Device Patient Labeling: Final Guidance for Industry and FDA Staff
April 19, 2001
Clinical Trial Guidance
Changes or Modifications During the Conduct of a Clinical Investigation; Final Guidance for Industry and CDRH Staff
May 29, 2001
Regulatory Submissions
Frequently-Asked-Questions about the Reprocessing and Reuse of Single-Use Devices by Third-Party and Hospital Reprocessors: Final Guidance for Industry and FDA Staff
July 6, 2001
Regulatory Submissions
Labeling Recommendations for Single-Use Devices Reprocessed by Third Parties and Hospitals: Final Guidance for Industry and FDA
July 30, 2001
Software
General Principles of Software Validation: Guidance for Industry and FDA Staff
January 11, 2002
Regulatory Submissions
Determination of Intended Use for 510(k) Devices – Guidance for CDRH Staff (Update to K98-1)
December 3, 2002
Quality System
Quality System Information for Certain Premarket Application Reviews : Guidance for Industry and FDA Staff
February 3, 2003
Regulatory Submissions
Pediatric Expertise for Advisory Panels – Guidance for Industry and FDA Staff
June 3, 2003
Regulatory Submissions
Premarket Approval Application Modular Review: Guidance for Industry and FDA Staff
November 3, 2003
Regulatory Submissions
Premarket Notification [510(k)] Submissions for Chemical Indicators – Guidance for Industry and FDA Staff
December 19, 2003
Regulatory Submissions
Medical Device User Fee and Modernization Act of 2002, Validation Data in Premarket Notification Submissions (510(k)s) for Reprocessed Single-Use Medical Devices: Guidance for Industry and FDA Staff
June 2, 2004
Regulatory Submissions
Frequently Asked Questions (FAQs) on the Status of Reprocessed Single Use Devices (SUDs) that receive a Not Substantially Equivalent (NSE) Letter
November 8, 2004
Medical Device
Cybersecurity for Networked Medical Devices Containing Off-the-Shelf (OTS) Software: Guidance for Industry
January 14, 2005
Software
Information for Healthcare Organizations about FDA’s “Guidance for Industry: Cybersecurity for Networked Medical Devices Containing Off-The-Shelf (OTS) Software”
February 9, 2005
Regulatory Submissions
Pharmacogenomic Data Submissions: Guidance for Industry
March 1, 2005
Other Resources
Click here to access a comprehensive and open access database, curated by Sepsis Alliance, of scholarly articles, patents, and other academic resources related to sepsis diagnostics. Our aim is to make innovation more accessible and inclusive by offering a resource for researchers, innovators, and other stakeholders to explore scientific trends, understand the intellectual property landscape, and identify new research opportunities.